Android app Apple app link

Trevi Therapeutics, Inc. (TRVI) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.56
Day's range
$13.29

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/07/2026 Raymond James Ryan Deschner $40.00 $18.50   116.22%
07/20/2026 H.C. Wainwright Brandon Folkes $24.00 $19.07   25.85%
05/08/2026 Stifel Nicolaus Annabel Samimy $30.00 $14.05   113.52%
11/19/2025 Leerink Partners Roanna Ruiz $16.00 $11.31   41.47%
11/14/2025 Morgan Stanley Judah Frommer $19.00 $11.68   62.67%
11/14/2025 Oppenheimer Leland Gershall $24.00 $11.80   103.39%
10/22/2024 H.C. Wainwright Oren Livnat $6.00 $3.35   79.1%
10/04/2024 B.Riley Financial Mayank Mamtani $6.00 $3.02   98.68%

Trevi Therapeutics Inc FAQ's

Trevi Therapeutics Inc has been rated by research analysts at Morgan Stanley, Oppenheimer, Raymond James, BMO Capital, H.C. Wainwright, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.